enVVeno Medical NVNO
NASDAQ NVNO
$7.80 -0.42 (-5.11%)
At close: Oct 2, 2026 · 4:00 PM EDT

enVVeno Medical (NVNO) Other Accumulated Expenses (2017 - 2026)

Updated

enVVeno Medical's Other Accumulated Expenses came in at $441,000 for Q2 2026, up 15.4% from the prior quarter.

Analysis

enVVeno Medical (NVNO) Other Accumulated Expenses (2017 - 2026) Analysis & Trends

At the end of FY2025, enVVeno Medical's Other Accumulated Expenses was $679,000, up 12.4% from FY2024.

  • Other Accumulated Expenses carries a five-year compound annual growth rate of 7.5% (FY2020 to FY2025).
  • Going back by year, Other Accumulated Expenses was $604,000 in FY2024 and $525,000 in FY2021 (+10.8%).
  • The five-year range for quarterly Other Accumulated Expenses is $294,000 (Q1 2022) to $679,000 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn
10 enVVeno Medical 5.25 Mn 5.25 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 441,000.00
Mar 31, 2026 382,000.00
Dec 31, 2025 679,000.00
Dec 31, 2024 604,000.00
Jun 30, 2022 374,000.00
Mar 31, 2022 294,000.00
Dec 31, 2021 525,000.00
Dec 31, 2020 473,799.00
Dec 31, 2017 20,558.00
API Access

enVVeno Medical Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=NVNO&period=max&api_key=YOUR_API_KEY